TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes - Huebner, H; Erber, R; Hein, A; Lux, MP; Jud, S; Kremer, AN; Kranich, H; Mackensen, A; Häberle, L; Hack, C; Rauh, C; Wunderle, M; Gaß, P; Rabizadeh, S; Brandl, AL; Langemann, H; Volz, B; Nabieva, N; Schulz-Wendtland, R; Dudziak, D; Beckmann, MW; Hartmann, A; Fasching, PA; Rübner, M (Geburtshilfe und Frauenheilkunde, 2018)